Predictors of therapeutic benefit from amitriptyline in mild depression: a general practice placebo-controlled trial

Journal of Affective Disorders

Volumn 14, Issue 1, 1988, Pages 83-95

  Paykel, E S ^a   Hollyman, J A ^a   Freeling, P ^a   Sedgwick, P ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Amitriptyline; Mild depression; Therapeutic benefit

Indexed keywords

AMITRIPTYLINE;

ADULT; CLINICAL ARTICLE; DEPRESSION; HUMAN; PSYCHOLOGICAL ASPECT;

ADOLESCENT; ADULT; AMITRIPTYLINE; CLINICAL TRIALS; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; HUMAN; MIDDLE AGE; PROGNOSIS; PSYCHOLOGICAL TESTS; SUPPORT, NON-U.S. GOV'T;

EID: 0023870837     PISSN: 01650327     EISSN: None     Source Type: Journal    
DOI: 10.1016/0165-0327(88)90075-4     Document Type: Article

References (47)

1. A controlled trial of imipramine in treatment of depressive states
2. Prediction of tricyclic antidepressant response: a critical review
3. A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both
4. The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination
5. Controlled trial of amitriptyline in general practice
6. The diagnosis of depressive syndromes and the prediction of ECT response
7. Drugs and group psychotherapy in neurotic depression
8. Effects of imipramine on individuals varying in level of depression
9. Pathways of specialist referral of depressed patients from general practice
10. Interaction of drug therapy with marital therapy in depressive patients
11. Differential treatment responsiveness among mildly depressed patients
12. Development of a rating scale for primary depressive illness
13. The severity of depression in patients treated in general practice
14. Neurotic illness and its response to anxiolytic and antidepressant treatment
15. Imipramine and chlordiazepoxide in depressive and anxiety disorders
16. Neurotic depression: a systematic analysis of multiple criteria and meanings
17. Phenelzine v imipramine in atypical depression
18. Are there anticompulsive or antiphobic drugs?
19. The efficacy of antidepressant drugs: a review of research (1958–1972)
20. Classification of depressed patients: a cluster analysis derived grouping
21. Predictors of treatment response
22. Life events and early environment
23. The clinical interview for depression
24. Response to phenelzine and amitriptyline in sub-types of neurotic depression
25. Depressive illness in a general practice
26. Research Diagnostic Criteria subtypes of depression: their role as predictors of differential response to psychotherapy and drug treatment
27. Classification of depression and response to amitriptyline therapy
28. Differential response to chlorpromazine, imipramine and placebo
29. Drug treatment of depressive illness: amitriptyline and chlordiazepoxide in two depressive populations
30. Content and consistency in the endogenous depressive pattern
31. The hidden mental health network
32. Treatment of endogenous anxiety with phobic hysterical and hypochondriacal symptoms
33. Cognitive therapy and pharmacotherapy for depression
34. Depression in general practice: case thresholds and diagnosis
35. Depression in general practice: clinical features and comparison with outpatients
36. Research Diagnostic Criteria: rationale and reliability
37. Efficacy of desipramine in depressed outpatients: response according to Research Diagnostic Criteria and severity of illness
38. Treatment outcome validation of DSM-III depressive subtypes: clinical usefulness in outpatients with mild to moderate depression
39. Cognitive therapy for major depressive disorder in primary care
40. The treatment of depression in general practice: a comparison of L-tryptophan, amitriptyline, and a combination of L-tryptophan and amitriptyline with placebo
41. Towards rational therapy with monoamine oxidase inhibitors
42. The influence of medication (imipramine) and doctor in relieving depressed psychoneurotic patients
43. A technique for studying psychiatric morbidity in inpatient and outpatient series and in general population samples
44. A comparison of imipramine, ECT and placebo in the treatment of depression
45. Treatment of agoraphobia with group exposure in vivo and imipramine